EGFR and cancer: MAPKs are the intracellular effectors of ErbB receptors (EGFR, ErbB2, ErbB3 and ErbB4), and hyperactivation of the ERK1/2 MAPK signaling pathway frequently occurs in human cancer and is associated with increased cell survival and proliferation [48].